Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayode Ogungbenro

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Paediatric Anaesthesia|November 18, 2018
A study of the dosage and duration for levobupivacaine infusion by the caudal-epidural route in infants aged 3-6 monthsRita Vashisht, Anju A Bendon, Ijeoma Okonkwo, et al.
Clinical Pharmacology and Therapeutics|August 4, 2021
Model-Based Drug-Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular AtrophyYumi Cleary, Michael Gertz, Paul Grimsey, et al.
The AAPS Journal|January 8, 2026
Virtual Twin-PBPK Modelling: A Step Toward Precision Dosing in Patients with ObesityHaribhau Kangne, Nihan Izat, Gong Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 22, 2023
Radiation in Combination with Immune Checkpoint Blockade and DNA Damage Response Inhibitors in Mice: Dosage Optimization in MC38 Syngeneic Tumors via Modelling and SimulationDavid Hodson, Hitesh Mistry, James Yates, et al.
Molecular Pharmaceutics|July 20, 2021
Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in RatsDaniel Scotcher, Nicola Melillo, Sirisha Tadimalla, et al.
Jac-Antimicrobial Resistance|February 27, 2024
Covariates in population pharmacokinetic studies of critically ill adults receiving β-lactam antimicrobials: a systematic review and narrative synthesisJan Hansel, Fahmida Mannan, Rebecca Robey, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 18, 2023
Mixed effects modeling of radiotherapy in combination with immune checkpoint blockade or inhibitors of the DNA damage response pathwayDavid Hodson, Hitesh Mistry, Sofia Guzzetti, et al.
Journal of the Intensive Care Society|December 29, 2025
A prospective cohort feasibility study of real-time beta-lactam antimicrobial therapeutic drug monitoring in critically ill patients with lower respiratory infection: The TDM-TIME studyJan Hansel, Jake Lain, Emmanuel O Erhieyovwe, et al.
Clinical Pharmacokinetics|May 6, 2023
Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug-Drug Interactions in ChildrenYumi Cleary, Heidemarie Kletzl, Paul Grimsey, et al.
British Journal of Clinical Pharmacology|November 21, 2024
Recommended approaches for integration of population pharmacokinetic modelling with precision dosing in clinical practiceMonika Berezowska, Isaac S Hayden, Andrew M Brandon, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Paediatric Anaesthesia|November 18, 2018
A study of the dosage and duration for levobupivacaine infusion by the caudal-epidural route in infants aged 3-6 monthsRita Vashisht, Anju A Bendon, Ijeoma Okonkwo, et al.
Clinical Pharmacology and Therapeutics|August 4, 2021
Model-Based Drug-Drug Interaction Extrapolation Strategy From Adults to Children: Risdiplam in Pediatric Patients With Spinal Muscular AtrophyYumi Cleary, Michael Gertz, Paul Grimsey, et al.
The AAPS Journal|January 8, 2026
Virtual Twin-PBPK Modelling: A Step Toward Precision Dosing in Patients with ObesityHaribhau Kangne, Nihan Izat, Gong Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 22, 2023
Radiation in Combination with Immune Checkpoint Blockade and DNA Damage Response Inhibitors in Mice: Dosage Optimization in MC38 Syngeneic Tumors via Modelling and SimulationDavid Hodson, Hitesh Mistry, James Yates, et al.
Molecular Pharmaceutics|July 20, 2021
Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in RatsDaniel Scotcher, Nicola Melillo, Sirisha Tadimalla, et al.
Jac-Antimicrobial Resistance|February 27, 2024
Covariates in population pharmacokinetic studies of critically ill adults receiving β-lactam antimicrobials: a systematic review and narrative synthesisJan Hansel, Fahmida Mannan, Rebecca Robey, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 18, 2023
Mixed effects modeling of radiotherapy in combination with immune checkpoint blockade or inhibitors of the DNA damage response pathwayDavid Hodson, Hitesh Mistry, Sofia Guzzetti, et al.
Journal of the Intensive Care Society|December 29, 2025
A prospective cohort feasibility study of real-time beta-lactam antimicrobial therapeutic drug monitoring in critically ill patients with lower respiratory infection: The TDM-TIME studyJan Hansel, Jake Lain, Emmanuel O Erhieyovwe, et al.
Clinical Pharmacokinetics|May 6, 2023
Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug-Drug Interactions in ChildrenYumi Cleary, Heidemarie Kletzl, Paul Grimsey, et al.
British Journal of Clinical Pharmacology|November 21, 2024
Recommended approaches for integration of population pharmacokinetic modelling with precision dosing in clinical practiceMonika Berezowska, Isaac S Hayden, Andrew M Brandon, et al.
Pageof 10